See the Complete Picture.
Published loading...Updated

Lonza says its US-based sites are in high demand as pharma tariffs near

Summary by Endpoints News
Lonza said on Friday it does not expect any “material financial impact” from current and potential pharma-specific tariffs, as the Swiss CDMO fields inquiries for its US-based facilities ...
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Endpoints News broke the news in on Friday, May 9, 2025.
Sources are mostly out of (0)